Screener
MapLight Therapeutics, Inc. MPLT Cash Flow Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| -$60.67M-172% | -$79.55M-275% | -$29.42M-54.7% | -$29.85M-62.2% | -$22.34M-18.0% | ||
| $162K-2.4% | $140K-27.8% | $100K-50.0% | $172K— | $166K— | ||
| $9.64M+4,445% | $35.52M+16,499% | —— | —— | $212K— | ||
| -$51.18M-100% | -$46.83M-118% | —— | —— | -$25.55M— | ||
| $24K— | $376K+255% | —— | —— | —— | ||
| $67.01M+78.7% | -$242.55M-1,101% | —— | —— | $37.5M+286% | ||
| -$6.85M-14,477% | $271.97M+5,439,200% | —— | —— | -$47K— | ||
| $8.98M-24.6% | —— | —— | —— | $11.9M+215% | ||
| -$51.2M— | -$47.21M-119% | —— | —— | —— |
FAQ
- How much cash does MapLight Therapeutics, Inc. generate?
- MapLight Therapeutics, Inc. (MPLT) generated -$145.0M in operating cash flow over the trailing twelve months.
- Where does MapLight Therapeutics, Inc.'s cash flow data come from?
- Every line is extracted from MapLight Therapeutics, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.